Skip to content
DataLookout
Menu

NCT06798194

Multimodal AI-based Region-specific Ablation Planning for Hepatocellular Carcinoma: Model Development, External Validation, and a Multicenter Randomized Trial

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Phase changed: Not specified → Not applicable Show 9 more changesShow less
    • Eligibility criteria expanded, about 6 words
    • Completed without a posted recruiting period
    • Final enrollment: 232 participants (planned 300)
    • Study completion date changed from estimate of Dec 30, 2027 to Nov 1, 2026
    • Trial arms changed: 0 → 2
    • Start date changed from estimate of Jan 30, 2025 to Jan 1, 2025
    • Secondary endpoint revised
    • Site contact updated
    • Study title revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Local tumor progression
Timeframe: 1 years

Secondary (1)

complication and volume of ablation zone

Arms and interventions

HCA-PS groupExperimental
control groupNo intervention

Diagnostic tests: Post-ablation MRI is used to evaluate whether the ablation area of the tumor is consistent with the highly conformal ablation thermal field provided by the AI model.

Sites

1 site in 1 country

  • Chinese PLA HospitalBeijing, China